Factors Influencing Patient Compliance With the App-Based Treatment Monitoring
comorbidity, tumor, Comorbidity
TUMOR
In a second step, clinical and patient-related covariates that could influence the feasibility of ePRO monitoring during radiotherapy in patients with HNC were analyzed. Patient age, gender, comorbidity burden (as assessed by the Charlson Comorbidity Index), the type of comorbidity (eg, cardiovascular, neurological, pulmonological, and nephrological), and smoking status did not show any correlation with the patient’s ability and willingness to undergo telemonitoring during radiotherapy. Similarly, tumor localization, tumor histology, or treatment concept did not influence the feasibility of ePRO monitoring. Detailed results can be found in 